Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc. is not affiliated in any way with Wire™ or Wire Swiss GmbH in any capacity.
7 employees · est. 2013 · Edison, United States
PlaqueTec Ltd.
Opening a new frontier in the fight against atherosclerosis
5 employees · est. 2008 · Cambridge, United Kingdom
PlaqueTec Ltd. is the older company (2013 vs 2008).
Side-by-Side Comparison
| Metric | Hepion Pharmaceuticals | PlaqueTec Ltd. |
|---|---|---|
| Founded | ||
| Founded | 2013 | 2008 older |
| Headquarters | ||
| Headquarters | Edison, United States | Cambridge, United Kingdom |
| Employees | ||
| Employees | 7 | 5 |
| Industry | ||
| Industry | Biotechnology, Life Sciences, Pharmaceutical | Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Series Unknown |
| Total Funding | ||
| Total Funding | $134.82M | $6.40M |
| Funding Rounds | ||
| Funding Rounds | 10 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Liver Disease, NASH, Chronic Hepatitis, Cirrhosis, Medication Therapies, Drug Development, CRV431, Clinical Trials, Hepatocellular Carcinoma, Fibrosis, Viral Hepatitis, Pharmacokinetics, Therapeutic Opportunities | Precision Medicine, Atherosclerosis, Coronary Artery Disease, Biomarker, Drug Development, Biopharmaceutical, Cardiology, Therapeutic Agents, Endotype, Clinical Trials, Inflammatory Processes, Plaque Progression, Vascular Function, Diagnostic Innovation |
| Website | ||
| Website | hepionpharma.com | plaquetec.com |
About Hepion Pharmaceuticals
Hepion Pharmaceuticals is a biopharmaceutical company established in 2013 and headquartered in the United States. The company is publicly traded on Nasdaq (HEPA) and focuses on developing a pleiotropic drug therapy for chronic liver diseases, specifically targeting fibrosis and hepatocellular carcin...
About PlaqueTec Ltd.
PlaqueTec Ltd. is revolutionizing the fight against atherosclerosis with their novel approach to understanding coronary artery disease (CAD). Their slogan, "Opening a new frontier in the fight against atherosclerosis," encapsulates their mission. CAD, a leading global cause of death, has been limite...
We will tell you when either one moves
BounceWatch watches Hepion Pharmaceuticals and PlaqueTec Ltd. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Hepion Pharmaceuticals and PlaqueTec Ltd. — by email.
Frequently Asked Questions
Compare Hepion Pharmaceuticals with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Hepion Pharmaceuticals on 12 Sep 2024, and PlaqueTec Ltd. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
